EUDA Health Holdings is a Singapore-headquartered company operating two businesses: property management services in Singapore and wellness products and services in Malaysia. Property management is the larger segment, contributing roughly 71% of revenue, and involves recurring, fee-based contracts to manage common areas and security at retail, office, and residential properties. The wellness business operates through CK Health, which EUDA acquired in May 2024. CK Health sells bioenergy cabin therapy sessions — capsule-like devices positioned as promoting detoxification and immune function — at its own treatment centers in Malaysia. CK Health holds exclusive distribution rights for these devices in Malaysia and charges customers per session. Since April 2025, CK Health has also been reselling stem cell therapy packages sourced from a Chinese provider, Guangdong Cell Biotech, with treatments administered at Guangdong Cell Biotech's centers in China. CK Health also holds exclusive distribution rights for the YOROYAL collagen product line in Malaysia, Vietnam, and Indonesia. EUDA's strategy is to shift revenue toward wellness services, with plans to expand geographically into Singapore and China, broaden into other regenerative medicine offerings, and launch a digital health and rewards platform using a utility token, though the platform remains early-stage. EUDA targets aging consumers in Southeast Asia and China seeking non-invasive, preventive healthcare. The company has generated recurring losses since 2020 and carries a going concern qualification, funding operations through equity issuances, convertible notes, and related-party loans.